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Background

Human Bladder

Probiotic bacteria, such as Lactobacilli, have been broadly used for many years in different
applications ranging from food safety to gut health. Their usefulness in these applications can be
attributed to the metabolites that they secrete to affect their surroundings. This research delved
into analysis of two strains of Lactobacillus recently cultured from the human bladder. Various
Lactobacilli are known to produce bacteriocins, which are small toxic peptides and proteins that
can have antimicrobial activity. This research project aimed to determine whether recent isolates
of Lactobacillus gasseri and Lactobacillus delbrueckii produce bacteriocins and can interact with
uropathogenic bacteria that cause urinary tract infections.

Approach

Bioinformatic Analysis:

Bladder Microbiome
Commensal
bacteria
Uropathogen

Results and Explanation
• Lactobacilli grow better on solid MRS
medium.
• Lactobacilli grow on sheep blood agar to
produce colonies for inoculations.
• Lactobacilli grow better when the agar plates
are sealed inside an airtight container.

The search of newly established whole genomes of two commensal
Lactobacilli strains S1 and S9, isolated from human bladder, predicts
the production of 2 different broad-spectrum toxins.

• Lactobacilli S1 and S9 inhibit growth of
laboratory Escherichia coli.
• The zones of inhibition can best be visualized
on MRS agar.
• Screening additional commensal strains of
Lactobacilli discovered more strains that cause
the inhibition of E. coli.

Experimental Analysis:
E. faecalis lawn is inhibited around
Lactobacilli wells.
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E. coli lawn is inhibited around wells
with six different Lactobacilli strains.

• Lactobacilli S1 and S9 also inhibit growth of
the uropathogenic strains of E. coli.
• Clinical isolates of multidrug resistant E. coli
are inhibited by Lactobacilli S1 and S9.
• Other notorious uropathogens Enterococcus
faecalis and Klebsiella pneumoniae were also
inhibited by the Lactobacilli S1 and S9
strains to different extents.
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Bioinformatically it was determined that both the S1 and S9
strains of Lactobacilli have a potential to produce bacteriocins:
Helveticin J and Enterolysin A. Initial experiments identified the
conditions for optimal growth of the newly isolated strains of
Lactobacilli. We discovered that both strains of Lactobacilli
interact with commensal and uropathogenic E. coli strains by
inhibiting their growth on solid and in liquid media. Remarkably,
the Lactobacilli also inhibited growth of clinical multidrug resistant
E. coli and two other uropathogenic species, E. faecalis and K.
pneumoniae. Screening of other bladder Lactobacilli strains
showed that many of them have great potential for inhibiting
uropathogens as well.
In the future, more experimentation will be needed to
determine exactly what components the Lactobacilli produce to
create the inhibitory effect. This could include pH adjustments,
oxidases, and bacteriocins. Ultimately, this research will be
foundational to developing a sustainable, alternative treatment to
antibiotics for urinary tract infections.

